GLOBAL LIVER INSTITUTE
Congress is in recess with Representatives and Senators back in districts and states connecting with their constituents prior to the elections. Their staff are working hard to prepare for what many hope to be a productive November legislative session where some legislative priorities may finally make it to final passage.
Welcome back to Liver Cancer News! As we mark Liver Cancer Awareness Month in October, we’re emphasizing the critical role of education and awareness in the fight against liver cancer through the #OctoberIs4Livers campaign. Read on for more information about the campaign and for updates on liver cancer care & prevention – especially for populations that face disparities in liver cancer care.
Despite awareness efforts, fatty liver disease remains largely overlooked in major global health strategies.
Ipsen has achieved progress in the fight against cholestatic diseases, marking two important victories for patients.
Global Liver Institute (GLI) launches its seventh annual #OctoberIs4Livers campaign to raise awareness of and address disparities in liver cancer in recognition of Liver Cancer Awareness Month.
Congress is entering a very busy work period in September, the last before the November elections. GLI is preparing for its Advanced Advocacy Academy (A3) and subsequent day on Capitol Hill to advocate for legislation!
Thank you for being a part of Liver Cancer News! As we gear up for Liver Cancer Awareness Month next month, we are thrilled to announce the launch of a comprehensive patient toolkit designed to support our community throughout their cancer journey.
With advancements in second-line treatments for PBC in 2024, both current and new treatment options must remain available, so that every patient can choose the treatment that best meets their needs.
New Clinical Practice Guidelines for MASLD, developed jointly by EASL, EASD, and EASO, update the 2016 guidelines to reflect recent advancements.
The Board of Directors of Global Liver Institute (GLI), the premier liver patient advocacy organization, has appointed Larry R. Holden as the organization’s Chief Executive Officer, as of September 2024.
Hepatitis C infection, an infection of the liver by the hepatitis C virus, is a major global health concern, affecting millions.
Clinical practice guidelines are evidence-based recommendations developed through systematic review and consensus to help healthcare providers and patients make informed decisions about the most appropriate treatment options for specific health conditions.
